The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies
A main concern in the management of patients with cancer-associated thrombosis (CAT) is drug-drug interactions (DDIs) between anticoagulants and anticancer therapies. Their clinical implications remain unclear.
Source: Thrombosis Research - Category: Hematology Authors: Tzu-Fei Wang, Madeleine Hill, Ranjeeta Mallick, Hina Chaudry, Ubabuko Unachukwu, Aur élien Delluc, Marc Carrier Tags: Full Length Article Source Type: research